Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges

V Fernandes, D Sharma, S Vaidya, S PA… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Current pharmacotherapeutics for neuropathic pain offer only symptomatic
relief without treating the underlying pathophysiology. Additionally, they are associated with …
被引用次数：60 相关文章

[引用][C] Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges

V Fernandes, D Sharma, S Vaidya, S PA… - Expert Opinion on …, 2018 - cir.nii.ac.jp
Cellular and molecular mechanisms driving neuropathic pain: recent advancements and
challenges | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges.

V Fernandes, D Sharma, S Vaidya, Y Guan… - Expert Opinion on …, 2018 - europepmc.org
Current pharmacotherapeutics for neuropathic pain offer only symptomatic relief without
treating the underlying pathophysiology. Additionally, they are associated with various dose …

Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges

V Fernandes, D Sharma, S Vaidya… - Expert opinion on …, 2018 - pure.johnshopkins.edu
Introduction: Current pharmacotherapeutics for neuropathic pain offer only symptomatic
relief without treating the underlying pathophysiology. Additionally, they are associated with …

Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges

V Fernandes, D Sharma, S Vaidya… - Expert opinion on …, 2018 - pubmed.ncbi.nlm.nih.gov
Current pharmacotherapeutics for neuropathic pain offer only symptomatic relief without
treating the underlying pathophysiology. Additionally, they are associated with various dose …